Post-approval studies (Phase 4)Study completedNCT02628106
What this trial is testing
Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy
Who this might be right for
Diabetic Nephropathy
West China Hospital 21